site:www.biopharma-reporter.com - 搜索图片

1500 x 1000 · jpeg
www.biopharma-reporter.com
AstraZeneca announces positive data for endometrial cancer treatment
1623 x 1082 · jpeg
www.biopharma-reporter.com
Thermo Fisher expands viral vector production capabilities
1500 x 1000 · jpeg
www.biopharma-reporter.com
EU recognition boosts Bimzelx’s profile as innovative interleukin-17 inhibitor t…
1500 x 1000 · jpeg
www.biopharma-reporter.com
ValGenesis launches end-to-end cleaning validation software

1500 x 1000 · jpeg
www.biopharma-reporter.com
Astraveus raises €16.5 million to advance cell and gene therapy manu…
1500 x 1000 · jpeg
www.biopharma-reporter.com
AstraZeneca’s Lynparza to remain dominant in PARP inhibitors market
1500 x 1000 · jpeg
www.biopharma-reporter.com
iSpecimen partners with TriMetis to ‘transform’ tissue-based research
1500 x 1000 · jpeg
www.biopharma-reporter.com
Regeneron gene therapy restores hearing in profoundly deaf child

2880 x 1374 · jpeg
www.biopharma-reporter.com
New biomanufacturing campus for California
1500 x 1000 · jpeg
www.biopharma-reporter.com
Life sciences: which US regions are on the rise?
1500 x 1000 · jpeg
www.biopharma-reporter.com
Archives - October 11, 2024 - Biopharma-Reporter.com
1500 x 1000 · jpeg
www.biopharma-reporter.com
Sygnature Discovery acquires NuChem Sciences

1500 x 1000 · jpeg
www.biopharma-reporter.com
Topical foam treatment for seborrheic dermatitis launches in US
1499 x 1000 · jpeg
www.biopharma-reporter.com
Archives - May 1, 2024 - Biopharma-Reporter.com
1500 x 1000 · jpeg
www.biopharma-reporter.com
Kyverna Therapeutics’ CAR-T cell therapy shows promise against autoi…
1500 x 1001 · jpeg
www.biopharma-reporter.com
CBM signs agreement for AAV vector manufacturing platform

1500 x 1000 · jpeg
www.biopharma-reporter.com
The future's bright for Vetter - interview with Carsten Press
1500 x 1000 · jpeg
www.biopharma-reporter.com
Alvotech’s AVT05 emerges as leading contender in rheumatoid arthritis ma…
1500 x 1000 · jpeg
www.biopharma-reporter.com
Vir Biotechnology awarded $10M grant by Bill & Melinda Gates Found…
1434 x 872 · jpeg
www.biopharma-reporter.com
Bionova Scientific announces plans for new Plasmid DNA GMP facility

1500 x 1001 · jpeg
www.biopharma-reporter.com
Gilead Sciences ‘strengthens commitment’ to inflammatory disease w…
1500 x 1239 · png
www.biopharma-reporter.com
Interview: Women in Science - Pamela Adede
1500 x 1000 · jpeg
www.biopharma-reporter.com
Bringing CAR-T into the community: ‘Healthcare is like politics – it’s local’
1500 x 1000 · jpeg
www.biopharma-reporter.com
Rentschler Biopharma: ‘Our strength is in our niche’

1500 x 1000 · jpeg
www.biopharma-reporter.com
Cell and Gene Therapy Catapult, Rentschler Biopharma and Refeyn …
1500 x 1000 · jpeg
www.biopharma-reporter.com
Ardena and RiboPro forge ‘strategic alliance’ to support RNA revolution
1500 x 866 · jpeg
www.biopharma-reporter.com
Candid Therapeutics launches to treat autoimmunity
1500 x 1000 · jpeg
www.biopharma-reporter.com
Janssen’s CAR-T multiple myeloma therapy gets greenlight from EMA

1500 x 1001 · jpeg
www.biopharma-reporter.com
What is ‘chemo mouth’ and could a brand new treatment offer relief?
1500 x 1000 · jpeg
www.biopharma-reporter.com
Axol Bioscience and StrataStem deliver ‘clinical trial in a dish’ for Alzheimer’s …
1500 x 1000 · jpeg
www.biopharma-reporter.com
ReNAgade Therapeutics launches with $300M financing to unlock ‘limitless p…
1500 x 1000 · jpeg
www.biopharma-reporter.com
Novo Nordisk pushes back after price gouging accusations by Bernie Sand…

3840 x 2160 · jpeg
www.biopharma-reporter.com
FDA lifts hold on BioNTech and MediLink's ADC trial
1500 x 1000 · jpeg
www.biopharma-reporter.com
Orano Med lays foundations for new radiopharmaceuticals manufacturing site
1500 x 1000 · jpeg
www.biopharma-reporter.com
Pfizer’s Velsipity UK approval to raise competition in ulcerative colitis market

某些结果已被隐藏，因为你可能无法访问这些结果。显示无法访问的结果